Luca Laurenti, MD

Department of Scienze di Laboratorio ed Ematologiche, Area Ematologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Roma, Italy

N/A

Poster(s):

• 1022 - Unravelling the Clinical and Biological Features of Accelerated Chronic Lymphocytic Leukemia

• 1220 - Chronic Lymphocytic Leukemia and Renal Cell Carcinoma: A Case Series of Twelve Patients

• 1435 - Absence of lymphocytosis after starting treatment with cBTKi is a rare phenomenon except for trisomy 12 and CD49d positive CLL

• 1708 - Chronic Obstructive Pulmonary Disease and Previous Pneumonia have an impact on infectious complications in patients with Chronic Lymphocytic Leukemia treated with Acalabrutinib and Zanubrutinib: a Multicentre SEIFEM Study.

• 1709 - Impact of Dose Intensity of Ibrutinib on Clinical Outcomes of CLL Patients: Analysis of the EVIdeNCE Study

• 1907 - Autoimmune cytopenias in patients with chronic lymphocytic leukemia receiving acalabrutinib treatment.